Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 15, 1997

View Archived Issues

Pharmacia & Upjohn describes HIV reverse transcriptase inhibitors

Japanese scientists report cholecystokinin antagonists

Potent antitumor agents described by Daiichi

Antifungal agent described by Roussel Morishita

New MDR modulators disclosed by Vertex

New antimigraine agent from Pfizer

PDE IV inhibitors revealed by Byk Gulden

New COX-2 inhibitor series reported by Merck Frosst

New PDE IV/TNF inhibitors from Chiroscience

Searle describes antiinflammatory oxazoles

Xoma expands pivotal Neuprex trials

Boston Life Sciences accelerates development of Altropane

AEterna accelerates anticancer clinical program

FDA proposes withdrawal of terfenadine products

Third set of phase III trials on Diatide imaging agent commences

Combination protease inhibitor trial with 141W94/VX-478

FDA clears antimetastatic carbohydrate compound for human trials

Aronex out-licenses antibody-toxin complex

Inhale/Centeon agreement for alpha1-proteinase inhibitor

SyStemix to be integrated into Novartis

Gene Logic/Baylor prostate cancer collaboration

Stanford researchers isolate breast cancer gene

Roche/Genentech marketing agreement for Roferon-A

3DP and ViroPharma establish drug discovery collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...